AU Patent

AU2024311205A1 — Treatment method and use of pharmaceutical combination containing conjugate

Assigned to Sichuan Kelun Biotech Biopharmaceutical Co Ltd · Expires 2026-01-22 · 0y expired

What this patent protects

The present invention relates to a treatment method and the use of a pharmaceutical combination containing a conjugate. Specifically, the present invention relates to a pharmaceutical composition, a kit and a treatment combination for treating cell proliferative disorders (e.g., …

USPTO Abstract

The present invention relates to a treatment method and the use of a pharmaceutical combination containing a conjugate. Specifically, the present invention relates to a pharmaceutical composition, a kit and a treatment combination for treating cell proliferative disorders (e.g., cancers), the use of the treatment combination, and a method for treating cell proliferative disorders (e.g., cancers).

Drugs covered by this patent

Patent Metadata

Patent number
AU2024311205A1
Jurisdiction
AU
Classification
—
Expires
2026-01-22
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Kelun Biotech Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.